Managing Director, New York, NY
Philippe Chambon, MD, PhD, is a Managing Director and founder of New Leaf Venture Partners. He concentrates on Information Convergence and Biopharmaceutical investments. He is currently on the board of Karos Pharmaceuticals, Treato, Ltd., Truveris, Inc. and VaxInnate Corporation. His career in Venture Capital started in 1995 when he joined The Sprout Group. Prior to that, he served as Manager in the Healthcare Practice of The Boston Consulting Group from 1993 to 1995. From 1987 to 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a M.D., Ph.D. from the University of Paris. Philippe also has an M.B.A. from Columbia University in New York.